We have investigated the feasibility of performing an automated pseudohomogeneous enzyme immunoassay in which a separation step is not apparent to the user. This was achieved using a layer of silicone fluid, which is immiscible with aqueous solutions, as a physical barrier between the pelleted and supernatant enzyme. Initially we produced a manual assay based on the Serozyrne T4 assay to demonstrate the feasibility of the approach. This assay showed good precision, parallelism and correlated with 'in house' results on patients' samples. Production of a fully automated assay was made difficult by the design of available equipment but none the less we demonstrated the feasibility of the automated approach by producing a standard curve for T4.
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Separation is a key step in many immunoassays and is invariably achieved by removal of an aqueous phase from above a solid phase. This places constraints on the design of automated immunoassays! but removal of the aqueous phase would not be required if a stable barrier could be introduced between the phases. Since silicone fluid can be used as a phase barrier in the separation of organelles.! we have investigated its use as a phase barrier between aqueous and solid phases in an immunoassay. We have designed an immunoassay in which separation is achieved without physical removal of the aqueous phase, the phases being kept apart by a layer of silicone fluid. The silicone fluid is less dense than the solid phase but more dense than the aqueous phase. We have termed this assay 'pseudohomogeneous' since a separation step is not apparent to the user.
Our aim is to develop an automated centrifugal pseudohomogeneous enzyme immunoassay in which a spinning cuvette generates the centrifugal force to separate 'bound' from 'free' and is also used to measure enzyme activity in the supernatant. As a first step in the development of this approach, it was important to demonstrate Correspondence: Dr G A Maguire.
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the applicability of the proposed phase separation method and we used as a model the Serozyme T4 assay (Serono Diagnostics Ltd, Woking, UK). This, after substantial modification, was adapted to the proposed assay format and a manual assay was developed and validated. We then conducted a preliminary investigation into its potential for automation using an IL Multistat III centrifugal analyser.
This report demonstrates the feasibility of our approach to the automation of immunoassays. The demonstration that silicone fluid provides an effective separation barrier between bound and free opens the door to the real possibilities of performing a heterogeneous immunoassay in a totally automated format.
MATERIALS AND METHODS

Reagents and equipment
Silicone fluids, Dow Corning 550 and 556, were obtained from BDH (Dorset, UK). 1'4 Serozyme kits and reagents were supplied by Serono Diagnostics. All other reagents were the purest grade available from either Sigma (Dorset, UK) or BDH. An IL Multistat III (lL (UK) Ltd, Warrington, UK) and a Serozyrne 1 filter photometer (Serono Diagnostics) were used throughout. The human serum specimens used in the study were from those submitted to the laboratory for routine thyroid function analysis.
Investigation of suitable density of silicone fluid Two stock silicone fluid solutions were obtained with densities of o· 98 and 1.07 g/mL. These were mixed to provide solutions of different densities. Into Eppendorf tubes, 200 JLL of each silicone fluid was placed, followed by 100 JLL of 'reaction mixture' (containing the appropriate mixture of sample, T4-fluorescein, anti-T4-alkaline phosphatase and solid phase, as set out in the T4 Serozyme protocol). The tubes were then spun for 10min at about 3000 rpm in an Eppendorf centrifuge. For each tube, the effectiveness of separation was noted visually.
Development of manual assay
Combinations of a range of T4-fluorescein, and anti-T4-alkaline phosphatase concentrations were investigated to determine concentrations for greatest sensitivity in differentiating between standards containing low, and high T4. The concentrations of T4-fluorescein and anti-T4-alkaline phosphatase investigated ranged between O· 5 and 10 times those used in the T4 Serozyme kit.
We used the experimentally determined most sensitive concentrations to develop a single tube assay. For this the alkaline phosphatase activity in the supernatant resting above the silicone fluid barrier was measured in situ using as substrate phenolphthalein monophosphate (PMP) in a fixed interval method. The released phenolphthalein was quantitated in the original assay tube using a Serozyme I filter photometer. This reads absorbances at two wavelengths 492 nm and 550 nm. The absorbance at 550 is five times that at 492. Thus if the absorbance is over 2' 0 at 550 nm, the absorbance reading at 492 nm can be taken and multiplied by five.
Description of manual assay protocol
To each 50 ILL of standard or sample, 200 ILL of T4-fluorescein (5 ng/mL) was added, followed by 200 ILL of anti-T4 (300 ng/mL). The preparations were mixed, and incubated at 37°C for 15 min. To each tube, 200 ILL of 0'60/0 anti-fluorescein solid phase was added; the solutions were mixed, and the preparations were incubated for a further 10 min at 37°C. Following incubation, the solid phase was separated from the supernatant by placing the tubes on a magnetic plate, then 250 ILL
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of silicone fluid was added to each tube. The tubes were then centrifuged at 3000 rpm for 5 min (20°-25°C), allowing the silicone fluid to form a layer separating the supernatant from the pellet. To each supernatant, 300 ILL of Serozyme PMP substrate was added. The solutions were gently mixed by flicking the tube, and left to incubate at room temperature. After 15 min, the reaction was stopped by the addition of l' 0 mL of Serozyme stop solution, and the solutions were mixed as before. The absorbance of each supernatant was measured at 492 and 550 nm on a Serozyme 1 spectrophotometer. Standard curves were drawn by hand on semi-log graph paper, which were then used to estimate T4 values. Each standard and sample was assayed in duplicate.
Automated assay protocol
Standard or sample was added manually in volumes of 5 ILL to the lower 'reagent' compartments of the rotor. This was followed by the addition of 20 ILL of T4-fluorescein (4 ng/ mL), then 20 ILL of anti-T4-alkaline phosphatase (60 ng/mL) to each reagent compartment. The solutions were mixed by manual manipulation of the rotor, then incubated at 30°C using the Multistat III 'incubate' mode for 15 min (rotor spins at 100 rpm, while the rotor housing attains 37°C. The spin speed is insufficient to have a centrifugal effect on the solutions). After incubation, 20 ILL of antifluorescein solid phase was added to each reagent compartment. The solutions were mixed as before, and incubated for a further 10 min at 37 cC. This was followed by the addition of 40 ILL of silicone fluid (1'07 g/mL). The rotor was spun using the 'run' mode (1000 rpm) for 10 min, during which the magnetic particles formed a pellet on the outside wall of each reagent compartment, with the silicone fluid forming a separation layer between the pellet and the supernatant. After spinning, 150 ILL of PMP substrate was added to the corresponding upper 'sample' compartments. The alkaline phosphatase programme of the Multistat III was then used to assess the supernatant activities.
RESULTS
Efficacy of silicone fluid as a barrier
A minimum density of 1·025 g/mL was required to form an effective barrier between pelleted solid phase antibody and immunoassay buffer but the high density of PMP alkaline phosphatase substrate solution necessitated the use of silicone fluid with a density of 1. 07 g/mL. Silicone fluid was demonstrated to act as an effective barrier in the measurement of solid phase alkaline phosphatase activity. Solid phase alkaline phosphatase was generated by incubation of sheep anti-mouse antibody coupled to magnetic particles and mouse anti-T4 antibody coupled to alkaline phosphatase. Less than 1070 of the solid phase activity was detected in the presence of the silicone fluid barrier. Furthermore, similar standard curves for T4 were obtained whether supernatants were withdrawn from the pellet and assayed separately or assayed in situ but separated from the pellet by a silicone fluid barrier. The optimal volume of silicone fluid for use in the assay was found to be 250 JLL. Smaller volumes tended to be easily displaced by the addition of other solutions, while much larger volumes interfered with the light path of the Serozyme 1. It was found that the separation of the solid phase from the supernatant was most effectively achieved if the magnetic particles were pelleted on a magnetic plate prior to the addition of silicone fluid. Pre-pelleting effectively reduced the length of spin required to achieve total separation of the pellet and supernatant by the silicone fluid. Centrifugation for 5 min at 3000 rpm (20°-25°C) was found to be sufficient to form a stable pellet beneath the silicone fluid. Figure 1 illustrates a curve in which the working range of the assay is covered using 10 calibrant concentrations. In practice it was not necessary to use such a wide range of standards, six calibrants adequately describing the shape of the curve.
Analysis of the manual assay Standard curve
Precision
Three Lyphochek<!' controls were used to estimate the within-batch and between-batch precision of the assay. Hand-drawn standard curves were used to estimate the T4 concentrations of each control (Table 1 ). In addition, the data collected for each point in 50 standard curves were expressed as a percentage of that obtained for the highest standard, and the means and standard deviations calculated. At all standard points the standard deviations were 3070 or less.
Accuracy
There is an anticipated drawback with using alkaline phosphatase labelled anti-T4 in the assay. Serum samples contain endogenous alkaline phosphatase and, unlike the Serozyme assay, the current assay does not incorporate a wash step to remove endogenous enzyme activity. We therefore corrected for endogenous alkaline phosphatase by assaying a 'blank' tube for every sample tube. Corrections for endogenous alkaline phosphatase activity were calculated by subtracting the mean blank absorbance value from the mean sample absorbance value, before interpolation on the corrected standard curve.
A total of 60 patient samples in five different batches were evaluated using the prototype assay and an in-house double antibody radioimmunoassay with a between batch coefficient of variation 3-5070 across the analytical range. The endogenous alkaline phosphatase of each sample was corrected for as described above. Introduction of this additional step reduced the precision of the assay. Nevertheless there was a good correlation between the two methods (manual assay = 4·3 + 1.05x reference method, r=0'85, n=6O, Fig. 2) .
A patient sample with a high concentration of T4 was diluted to 75070,50070, and 25070 of the initial concentration. The T4 concentration in 
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Cuvette design each dilution was evaluated using the manual assay, with correction for endogenous alkaline phosphatase. The T4 concentration was found to decrease proportionately with increasing dilution of the sample.
Investigation of the feasibility of automation
The design of the centrifugal analyser imposed constraints on the adaption of the manual assay to an automated format. These constraints included; the rotor design which limited the amount of silicone fluid which could be added without obscuring the light path and which provided only a limited space to accommodate the pelleted solid phase; the relatively slow speed of centrifugation which did not sufficiently compact the pellet; and the programming of the analyser which automatically remixed the pellet before analysis. Strategies to overcome these problems were adopted and an assay protocol developed as described above. We were able to demonstrate the feasibility of full automation by generating a standard curve for T4 estimation (results not shown).
DISCUSSION
This paper describes a new approach to the automation of immunoassays. The results of our investigation provide the basis for the development of a new type of fully-automated heterogeneous immunoassay. The use of a phase barrier to separate bound from free in our procedure is a novel concept with no previous use, to our knowledge, in immunoassays. Silicone fluids have been used previously as phase barriers, primarily in the separation of cells from culture media or cell lysates':" and in the separation of cell organelles from the cytoplasmic fraction. 2 ,6,7 These experiments have shown the effectiveness of silicone fluids in the segregation of aqueous phase from solid phase. The selected silicone fluid employed in our manual assay proved to be an effective phase separation barrier with less than 1% interference from activity bound in the pellet.
We developed a manual assay for T4, in which all steps were conducted in a single test tube. Using the manual assay, results on patient samples correlated with those from a T4 radioimmunoassay (Fig. 2) . However, human serum samples contain alkaline phosphatase which, if not corrected for, would lead to inaccurate estimations of sample T4 since alkaline phosphatase is used to label the anti-T4 antibody. Consequently, we had to correct for endogenous alkaline phosphatase and this led to poorer precision as the result of the cumulative error generated by the additional protocol steps. This problem would be overcome by use of an alternative enzyme label not found in human serum, e.g. {3-galactosidase.
Automation of the assay was attempted on an IL Multistat III centrifugal analyser. Problems were encountered with maintaining the separation of the solid phase and the supernatant. Although separation was stable whilst the rotor was spinning, the inbuilt programming of the Multistat III imposed restrictions on the speed at which the rotor could be spun, and included a step which mixed the contents of each cuvette prior to the measurement of enzyme activity. The introduction into the protocol of a delay interval after mixing to re-establish the separation allowed us to measure activity using an anti-T4-alkaline phosphatase concentration of 60 ng/mL, and standard curves were obtained using the lower concentration. The problems outlined above are the result of the design of the Multistat rotor (Fig. 3) . The rotor cuvettes have blunt end-walls, and allow only a narrow margin between the endwall and the light path. Consequently, the contents of the cuvette are easily dispersed by the effects of gravity and the addition of solutions to the cuvette. These problems could be overcome by modification of the design of the MuItistat rotor cuvette shape. Strategies for overcoming problems with the stability of separation could also include the re-designing or re-programming of the centrifugal analyser itself. Lentrichia et al. (1987) re-programmed a Multistat III 'Plus' centrifugal analyser to generate the g-forces needed for their immunoassay based on differential centrifugation of latex particles of differing densities." It is probable that an increased centrifugal force on the reagents would greatly improve the stability of the separation, but unfortunately it is not possible to re-programme the Multistat III to spin the rotor faster. Although the Multistat provided a faster spin mode (4000 rpm), it could not be used routinely, being potentially damaging to the machine. A programmable version of the Multistat could contribute significantly to the achievement of a stable silicone fluid-based separation and hence the development of a fully-automated immunoassay.
We have shown that it is possible to conduct a heterogeneous immunoassay in a single test tube using silicone fluid as a stable separation barrier between found and free moiety. With instruments and equipment of a suitable design, this working manual assay could be converted to a fully-automated format. Investigation into the reprogramming of existing centrifugal analysers and research into the modification of rotor cuvette design are a prerequisite to the development of a fully-automated heterogeneous immunoassay. Additionally, there are alternative avenues of research worthy of exploration. The development of a heterogeneous automated centrifugal immunoassay may also be achieved by exploring the possibilities of such concepts as coating specific areas of a rotor with the appropriate antibody, or attaching an antibody to particles less dense than the liquid phase, as opposed to more dense. Our demonstration that silicone fluid can act as an effective phase separation barrier in a heterogeneous immunoassay could create possibilites for the development of manual or automated 'pseudohomogeneous ' immunoassays of varying design.
